1
|
Roerink AMC, Nelissen RGHH, Holder C, Graves SE, Dunbar M, Bohm E, Grimberg AW, Steinbrück A, Dale H, Fenstad AM, Blom AW, Lenguerrand E, Frampton C, Willems T, Victor J, Espallargues M, Arias-de la Torre J, Ciminello E, Torre M, Pijls BG. Sex-based differences in risk of revision for infection after hip, knee, shoulder, and ankle arthroplasty in osteoarthritis patients: a multinational registry study of 4,800,000 implants. Acta Orthop 2024; 95:730-736. [PMID: 39656214 PMCID: PMC11632196 DOI: 10.2340/17453674.2024.42183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 10/02/2024] [Indexed: 12/13/2024] Open
Abstract
BACKGROUND AND PURPOSE We aimed to determine sex differences for periprosthetic joint infections after primary arthroplasty of the hip, knee, ankle, and shoulder in osteoarthritis patients in an international perspective. METHODS This is a multinational combined arthroplasty registry study. Each arthroplasty registry performed Cox-regression analysis of their data and reported the crude and adjusted hazard ratios (HR) with an a priori designed data form. A random-effects model was used to pool these HRs to estimate an overall HR with 95% confidence interval (CI). Adjustment was undertaken for patient age, BMI, ASA grade, type of fixation, and type of implant. 9 arthroplasty registries participated. Patients who received primary total joint arthroplasty for primary osteoarthritis were considered: 2,134,313 hip arthroplasties, 2,658,237 knee arthroplasties, 57,889 shoulder arthroplasties, and 8,445 ankle arthroplasties. We calculated hazard ratios (HR) for the overall risk of complete revision due to infection for each implant type and follow-up. RESULTS The pooled HR for revision due to infection for men compared with women at 1-year follow-up was 1.60 (95% confidence interval [CI] 1.42-1.80) for hip arthroplasties; 2.06 (CI 1.90-2.46) for knee arthroplasties; 4.51 (CI 2.99-6.80) for shoulder arthroplasties; and 0.87 (CI 0.46-1.62) for ankle arthroplasties. These results remained consistent over time and were identified in both unadjusted and adjusted models. CONCLUSION Men have a higher risk of revision due to infection than women after primary hip, knee, and shoulder arthroplasty. No evidence of difference was found for ankle arthroplasty. These elevated relative risks persist in the fully adjusted investigations and over the 10-year postoperative period studied.
Collapse
MESH Headings
- Humans
- Male
- Female
- Registries
- Reoperation/statistics & numerical data
- Prosthesis-Related Infections/epidemiology
- Prosthesis-Related Infections/etiology
- Aged
- Middle Aged
- Sex Factors
- Risk Factors
- Osteoarthritis/surgery
- Arthroplasty, Replacement, Hip/adverse effects
- Arthroplasty, Replacement, Ankle/adverse effects
- Arthroplasty, Replacement, Shoulder/adverse effects
- Arthroplasty, Replacement, Knee/adverse effects
- Proportional Hazards Models
- Osteoarthritis, Hip/surgery
- Arthroplasty, Replacement/adverse effects
Collapse
Affiliation(s)
- Anne M C Roerink
- Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
| | - Rob G H H Nelissen
- Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
| | - Carl Holder
- South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
| | - Stephen E Graves
- Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), Adelaide; Clinical and Health Sciences, University of South Australia, Adelaide, Australia
| | - Michael Dunbar
- Division of Orthopaedics, Dalhousie University, Halifax, Nova Scotia; Canadian Joint Replacement Registry, Canada
| | - Eric Bohm
- Canadian Joint Replacement Registry; Concordia Joint Replacement Group, University of Manitoba, Winnipeg, Canada
| | - Alexander W Grimberg
- German Arthroplasty Registry (EPRD Deutsche Endoprothesenregister gGmbH), Berlin, Germany
| | - Arnd Steinbrück
- German Arthroplasty Registry (EPRD Deutsche Endoprothesenregister gGmbH), Berlin, Germany
| | - Håvard Dale
- The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen; Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Anne Marie Fenstad
- The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway
| | - Ashley W Blom
- Bristol Medical School, University of Bristol, Bristol, UK
| | | | | | - Tine Willems
- Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium
| | - Jan Victor
- Department of Orthopedics and Traumatology; Ghent University, Ghent University Hospital, Ghent, Belgium
| | - Mireia Espallargues
- gència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain
| | - Jorge Arias-de la Torre
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; 17 Care in Long Term Conditions Research Division, King's College London, London, UK; CIBER Epidemiology and Public Health (CIBERESP), Madrid; Institute of Biomedicine (IBIOMED). Universidad de León, León, Spain
| | - Enrico Ciminello
- Italian Arthroplasty Registry (RIAP), Rome; Italian National Institute of Health, Rome, Italy
| | - Marina Torre
- Italian Arthroplasty Registry (RIAP), Rome; Italian National Institute of Health, Rome, Italy
| | - Bart G Pijls
- Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.
| |
Collapse
|
2
|
Kadakia KT, Rathi VK, Dhruva SS, Ross JS, Krumholz HM. Modernizing Medical Device Regulation: Challenges and Opportunities for the 510(k) Clearance Process. Ann Intern Med 2024; 177:1558-1565. [PMID: 39374526 DOI: 10.7326/annals-24-00728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/09/2024] Open
Abstract
Nearly all medical devices reviewed by the U.S. Food and Drug Administration (FDA) are authorized via the 510(k) clearance process. Established in 1976, this review pathway bases authorizations on the comparability of new devices to previously authorized devices ("predicates"). This evaluation usually does not require clinical evidence of safety and effectiveness. Advocates of the 510(k) clearance process tout its support for device innovation and rapid market access, and critics of the 510(k) clearance process express that it may inadequately protect patient safety. In September 2023, the FDA issued 3 guidance documents that, if finalized, would significantly change medical device regulation. This article provides clinical and regulatory context for the proposed guidance documents, which focus on predicate selection, clinical testing requirements, and implantable devices, and identifies opportunities for further reforms that promote transparency and patient safety.
Collapse
Affiliation(s)
| | - Vinay K Rathi
- Department of Otolaryngology - Head and Neck Surgery, The Ohio State University College of Medicine, Columbus, Ohio (V.K.R.)
| | - Sanket S Dhruva
- Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, and Section of Cardiology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California (S.S.D.)
| | - Joseph S Ross
- Section of General Internal Medicine, Department of Internal Medicine, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, and Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut (J.S.R.)
| | - Harlan M Krumholz
- Center for Outcomes Research and Evaluation, Yale New Haven Hospital, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, and Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut (H.M.K.)
| |
Collapse
|
3
|
Warren SI, Hwang KL, Lee JJ, Murrietta AJ, Koltsov JCB, Goodman SB. Primary Total Hip Arthroplasty in Juvenile Idiopathic Arthritis: Survivorship After a Median Follow-Up of 12 Years. J Arthroplasty 2024; 39:1530-1534. [PMID: 38104785 DOI: 10.1016/j.arth.2023.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 12/10/2023] [Accepted: 12/12/2023] [Indexed: 12/19/2023] Open
Abstract
BACKGROUND Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition of childhood that frequently affects the hip. Total hip arthroplasty (THA) in JIA can be challenging due to the patient's young age, small proportion, complex anatomy, and bone loss. Outcome data are limited. METHODS We reviewed prospectively collected data in 57 JIA patients (83 hips) who underwent THA between 1986 and 2020 by a single surgeon. The median patient age at surgery was 26 years (range, 14 to 62). Reoperation-free survival was assessed via the cumulative incidence function, accounting for the competing risk of death. Relationships between patient and implant factors and survivorship were evaluated by stratification of the cumulative incidence function and Gray's tests. Wilcoxon signed rank tests were used to assess the preoperative to latest postoperative change in patient-reported outcome measures. RESULTS At a median (interquartile range) of 12 (4, 20) years of follow-up, 13 (16%) patients underwent reoperation, most commonly for polyethylene wear and osteolysis (7 hips). The estimated incidence of 10-year, 20-year, and 30-year revision (95% confidence interval) were 11.3% (4.5, 21.6%), 18.5% (8.9, 30.9%), and 40.6% (19.4, 60.9%), respectively. There were no differences in survival based on patient age, sex, implant fixation method, polyethylene type, or thickness. All patient-reported outcome measures improved from preoperative to latest follow-up. CONCLUSIONS Primary THA is a durable and effective treatment for JIA patients with severe hip involvement and results in major improvements in pain and function. We did not identify any factors predictive of failure.
Collapse
Affiliation(s)
- Shay I Warren
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| | - Katherine L Hwang
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| | - Jonathan J Lee
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| | - Adam J Murrietta
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| | - Jayme C B Koltsov
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| | - Stuart B Goodman
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California
| |
Collapse
|
4
|
Ladurner A, Zdravkovic V, Giesinger K. Sex-Specific Implant Fixation Can Reduce Revision Rates in Total Hip Arthroplasty: Evidence From the Swiss National Joint Registry. J Arthroplasty 2024; 39:421-426. [PMID: 37595764 DOI: 10.1016/j.arth.2023.08.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 08/08/2023] [Accepted: 08/09/2023] [Indexed: 08/20/2023] Open
Abstract
BACKGROUND Patient's sex is considered a risk factor for revision following primary total hip arthroplasty (THA), but sex-specific treatment guidelines are lacking. The purpose was to assess sex-specificity of risk factors for periprosthetic femoral fractures (PFFs) and aseptic stem loosening (ASL) in a nationwide register study. METHODS All uncemented and hybrid THAs for hip osteoarthritis registered in the Swiss National Joint Registry were considered. 86,423 THAs were analyzed. Comparable THA subsets for both sexes were obtained through propensity score matching (1:1). A sex-specific analysis of risk factors for early PFF or ASL was performed using recursive partitioning analyses. RESULTS In women, PFFs were most significantly associated with uncemented THA fixation (P < .0001) and age (P < .01, threshold: 70.5 years). The ASLs were solely associated with patient age of <65 years (P = .023). In men, PFFs were associated exclusively with an American Society of Anesthesiologists (ASA) score >2 (P = .026). The ASLs were not correlated to any of the potential risk factors analyzed. A mathematical simulation indicated that avoiding uncemented THA fixation in women ≥70.5 years of age decreased the number of revisions within the observational period by 21% in this subset and by 4.9% in the entire patient population. CONCLUSION Uncemented THA should be avoided in women >70.5 years due to the increased risk of early PFF, while the mode of stem fixation did not influence revision risk in men. A sex-specific regimen for THA fixation has the potential to markedly reduce early THA revision rates.
Collapse
Affiliation(s)
- Andreas Ladurner
- Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
| | - Vilijam Zdravkovic
- Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
| | - Karlmeinrad Giesinger
- Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
| |
Collapse
|
5
|
Jang SJ, Fontana MA, Kunze KN, Anderson CG, Sculco TP, Mayman DJ, Jerabek SA, Vigdorchik JM, Sculco PK. An Interpretable Machine Learning Model for Predicting 10-Year Total Hip Arthroplasty Risk. J Arthroplasty 2023:S0883-5403(23)00336-4. [PMID: 37019312 DOI: 10.1016/j.arth.2023.03.087] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 03/20/2023] [Accepted: 03/25/2023] [Indexed: 04/07/2023] Open
Abstract
BACKGROUND As the demand for total hip arthroplasty (THA) rises, a predictive model for THA risk may aid patients and clinicians in augmenting shared decision-making. We aimed to develop and validate a model predicting THA within 10 years in patients using demographic, clinical, and deep learning (DL)-automated radiographic measurements. METHODS Patients enrolled in the Osteoarthritis Initiative were included. DL algorithms measuring osteoarthritis- and dysplasia-relevant parameters on baseline pelvis radiographs were developed. Demographic, clinical, and radiographic measurement variables were then used to train generalized additive models to predict THA within 10 years from baseline. A total of 4,796 patients were included (9,592 hips; 58% female; 230 THAs (2.4%)). Model performance using 1) baseline demographic and clinical variables 2) radiographic variables, and 3) all variables were compared. RESULTS Using 110 demographic and clinical variables, the model had a baseline area under the receiver operating curve (AUROC) of 0.68 and area under the precision recall curve (AUPRC) of 0.08. Using 26 DL-automated hip measurements, the AUROC was 0.77 and AUPRC was 0.22. Combining all variables, the model improved to an AUROC of 0.81 and AUPRC of 0.28. Three of the top five predictive features in the combined model were radiographic variables including minimum joint space along with hip pain and analgesic use. Partial dependency plots revealed predictive discontinuities for radiographic measurements consistent with literature thresholds of osteoarthritis progression and hip dysplasia. CONCLUSION A machine learning model predicting 10-year THA performed more accurately with DL radiographic measurements. The model weighted predictive variables in concordance with clinical THA-pathology assessments.
Collapse
Affiliation(s)
- Seong Jun Jang
- Weill Cornell College of Medicine, New York, NY, USA; Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA.
| | - Mark A Fontana
- Weill Cornell College of Medicine, New York, NY, USA; Center for Analytics, Modeling, and Performance, Hospital for Special Surgery, New York, NY, USA
| | - Kyle N Kunze
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | | | - Thomas P Sculco
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA; Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, NY, USA
| | - David J Mayman
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA; Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, NY, USA
| | - Seth A Jerabek
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA; Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, NY, USA
| | - Jonathan M Vigdorchik
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA; Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, NY, USA
| | - Peter K Sculco
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA; Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, NY, USA
| |
Collapse
|
6
|
Intermuscular Fat, But Not Subcutaneous Fat, Correlated With Major Complications After Primary Total Hip Arthroplasty. Acad Radiol 2022:S1076-6332(22)00505-0. [DOI: 10.1016/j.acra.2022.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 09/13/2022] [Accepted: 09/16/2022] [Indexed: 11/22/2022]
|